Brief: Moleculin Announces Acceptance Of Abstract To Be Presented At The American Association For Cancer Research Annual Meeting 2025
17/04/2025 13:54
April 17 (Reuters) - Moleculin Biotech Inc MBRX.O: MOLECULIN ANNOUNCES ACCEPTANCE OF ABSTRACT TO BE PRESENTED AT THE AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) ANNUAL MEETING 2025 Source text: ID:nGNX48jC8T Further company coverage: MBRX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Moleculin Biotech
See all newsMoleculin Biotech Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Moleculin Secures Australian Patent For Annamycin Formulation Technology
Moleculin Biotech Inc expected to post a loss of $8.87 a share - Earnings Preview
Brief: Moleculin Biotech Completes Dosing In Part A Of Miracle Trial Data Readout On Track For Q1 2027
NASDAQ RESUMED AT 09:00 AM